Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

23.20
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
12.25
Today|||52-Week Range
23.35
+28.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues1.3M3.6M8.5M8.6M
 
 
 
 
 
Cost of Goods Sold35.0K857.0K601.0K646.0K
 
 
 
 
 
Depreciation And Amortization306.0K329.0K412.0K405.0K
 
 
 
 
 
 
Operating ExpensesGross Income938.0K2.4M7.5M7.5M
 
 
 
 
 
General Expenses47.7M50.6M49.0M48.6M
 
 
 
 
 
Research And Development29.5M32.6M28.0M28.6M
 
 
 
 
 
Total Operating Expenses48.1M51.8M50.0M49.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-46.8M-48.2M-41.5M-41.1M
 
 
 
 
 
Extraordinary Charge---1.1M-600.0K-200.0K
 
 
 
 
Interest Expense On Debt1.6M1.0M744.0K552.0K
 
 
 
 
 
Other Expenses436.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-48.0M-50.3M-42.8M-41.9M
 
 
 
 
 
Net Income-48.0M-50.3M-42.8M-41.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.3M50.5M53.8M54.2M
 
 
 
 
 
Shares To Calculate EPS Diluted39.3M50.5M53.8M54.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.22-$1.00-$0.80-$0.77
 
 
 
 
 
EPS Diluted-$1.22-$1.00-$0.80-$0.77